ClassID:

94427

C07D233/78 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom Radicals substituted by oxygen atoms

Recent Application in this class:
#1
20250136555
2025-05-01

HYDANTOIN COMPOUND AND MEDICAL USE THEREOF

#2
20240425547
2024-12-26

PSMA Imaging Agents

#3
20240409580
2024-12-12

PSMA Imaging Agents

#4
20220017486
2022-01-20

DOCK1-INHIBITING COMPOUND AND USE THEREOF

#5
20210309614
2021-10-07

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#6
20210130301
2021-05-06

Compositions for the treatment of pulmonary fibrosis

#7
20210032286
2021-02-04

PSMA Imaging Agents

#8
20210024574
2021-01-28

PSMA imaging agents

#9
20200377549
2020-12-03

PSMA imaging agents

#10
20200216397
2020-07-09

5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#11
20200119359
2020-04-16

OLIGOMER AND LITHIUM BATTERY

#12
20200010425
2020-01-09

Compounds useful as modulators of TRPM8

#13
20190270712
2019-09-05

Compositions for the treatment of pulmonary fibrosis

#14
20190077787
2019-03-14

Imide derivatives and use thereof as medicine

#15
20190023690
2019-01-24

Inhibitors of cellular necrosis and related methods

#16
20180297957
2018-10-18

Compounds, polymers and coating formulations that comprise at least one N-halamine precursor, a cationic center and a coating incorporation group

#17
20180258134
2018-09-13

PSMA imaging agents

#18
20180258052
2018-09-13

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#19
20180127368
2018-05-10

Tricyclic sulfones as ROR gamma modulators

#20
20180072682
2018-03-15

Compositions for the treatment of fibrosis and fibrosis-related conditions

#21
20180002293
2018-01-04

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#22
20170369447
2017-12-28

Compounds useful as modulators of TRPM8

#23
20170369428
2017-12-28

Selective histone deactylase 6 inhibitors

#24
20160304555
2016-10-20

PSMA imaging agents

#25
20160289282
2016-10-06

Synthesis of hydantoin containing peptide products

#26
20160229819
2016-08-11

Fumarate compounds, pharmaceutical compositions thereof, and methods of use

#27
20160185716
2016-06-30

Selective histone deactylase 6 inhibitors

#28
20160168128
2016-06-16

Inhibitors of cellular necrosis and related methods

#29
20150376136
2015-12-31

Compounds useful as modulators of TRPM8

#30
20150252006
2015-09-10

Inhibitors of peptidyl arginine deiminase (PAD) enzymes and uses thereof

#31
20150218107
2015-08-06

Aggrecanase inhibitors

#32
20140058114
2014-02-27

Cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives

#33
20120309803
2012-12-06

Ester compound and use thereof

#34
20120309802
2012-12-06

Ester compound and use thereof

#35
20120015994
2012-01-19

(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors

#36
20100280013
2010-11-04

Carbinol derivatives having heterocyclic linker

#37
20100247583
2010-09-30

N-phenylacetamide inhibitors of the enzyme SOAT-1 and pharmaceutical/cosmetic compositions comprised thereof

#38
20100228015
2010-09-09

PRODRUG DERIVATIVES OF ACIDS USING ALCOHOLS WITH HOMOTOPIC HYDROXY GROUPS AND METHODS FOR THEIR PREPARATION AND USE

#39
20100210699
2010-08-19

Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such

#40
20100174092
2010-07-08

5 substituted hydantoins

#41
20100143981
2010-06-10

WHOLE-CELL CATALYTIC SYSTEM COMPRISING A HYDANTOINASE, A RACEMASE AND A CARBAMOYLASE

#42
20100105719
2010-04-29

Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors

#43
20100063120
2010-03-11

Imidazolidine Derivatives, Uses Therefor, Preparation Thereof and Compositions Comprising Such

#44
20100063119
2010-03-11

Substituted carbinol compound

#45
20090281101
2009-11-12

Therapeutic substituted hydantoins, and related compounds

#46
20090227604
2009-09-10

Vitamin D receptor modulators

#47
20090215846
2009-08-27

(2,5-dioxoimidazolidin-1-yl)-N-hydroxy-acetamides as metalloproteinase inhibitors

#48
20090170920
2009-07-02

Substituted hydantoins

#49
20090099186
2009-04-16

INHIBITORS OF VIRAL REPLICATION

#50
20090076045
2009-03-19

Non-nucleoside reverse transcriptase inhibitors

#51
20090030056
2009-01-29

Sodium channel blockers

#52
20090018058
2009-01-15

Vitamin D receptor modulators

#53
20080241896
2008-10-02

PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE HYDROXYMETHYL-SUBSTITUTED PHENYLALANINE

#54
20080226618
2008-09-18

Hydantoin derivatives useful as antibacterial agents

#55
20080058397
2008-03-06

Therapeutic substituted hydantoins and related compounds

#56
20070254920
2007-11-01

Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use

#57
20070232661
2007-10-04

Hedgehog pathway antagonists

#58
20070208001
2007-09-06

Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same

#59
20070197617
2007-08-23

Substituted hydantoins

#60
20070155810
2007-07-05

Peptide deformylase inhibitors

#61
20070111982
2007-05-17

Carboxamide spirohydantoin CGRP receptor antagonists

#62
20070043121
2007-02-22

Discovery of novel soluble crystalline anesthetics

#63
20060276524
2006-12-07

2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12

#64
20060142363
2006-06-29

Imidazolidinedione analogs useful as anticoagulants and antithrombotics

#65
20050245586
2005-11-03

2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12

#66
20050228033
2005-10-13

Sodium channel blockers

#67
20050154028
2005-07-14

Cyclic urea derivatives with 5-ht2c receptor activity

#68
20050153968
2005-07-14

Monocyclic -Aryl hydantoin modulators of androgen receptor function

#69
20050124677
2005-06-09

Peptide deformylase inhibitors